Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/serum-omentin-1-and-chemerin-levels-are-interrelated-in-patients-with-xZN7HGe72t
References (31)
-
S. Kralisch, S. Weise, G. Sommer, J. Lipfert, U. Lossner, M. Bluher, M. Stumvoll, M. Fasshauer (2009)
Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitroRegulatory Peptides, 154
-
Rongze Yang, Mi-Jeong Lee, Hong Hu, Jessica Pray, Hai-bin Wu, B. Hansen, A. Shuldiner, S. Fried, J. Mclenithan, D. Gong (2006)
Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.American journal of physiology. Endocrinology and metabolism, 290 6
-
S. Wurm, M. Neumeier, J. Weigert, A. Schäffler, C. Buechler (2007)
Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adultsCardiovascular Diabetology, 6
-
A. Tönjes, M. Fasshauer, J. Kratzsch, M. Stumvoll, M. Blüher (2010)
Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and DiabetesPLoS ONE, 5
-
Matthew Ernst, C. Sinal (2010)
Chemerin: at the crossroads of inflammation and obesityTrends in Endocrinology & Metabolism, 21
-
A. Schäffler, M. Neumeier, H. Herfarth, A. Fürst, J. Schölmerich, C. Büchler (2005)
Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue.Biochimica et biophysica acta, 1732 1-3
-
Hongyan Pan, Lin Guo, Qiang Li (2010)
Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.Diabetes research and clinical practice, 88 1
-
D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner (1985)
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 28
-
Simon Bronner, Vincent Tortora (1979)
Old Order AmishJournal of American Folklore, 92
-
Wenchao Hu, P. Feng (2011)
Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients.Diabetes research and clinical practice, 91 2
-
B. Antuna-Puente, B. Fève, S. Fellahi, J. Bastard (2008)
Adipokines: the missing link between insulin resistance and obesity.Diabetes & metabolism, 34 1
-
M. Burstein, H. Scholnick, R. Morfin (1970)
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.Journal of lipid research, 11 6
-
Michiko Takahashi, Yutaka Takahashi, Kenichi Takahashi, Fyodor Zolotaryov, Kyoung Hong, R. Kitazawa, K. Iida, Y. Okimura, H. Kaji, S. Kitazawa, M. Kasuga, K. Chihara (2008)
Chemerin enhances insulin signaling and potentiates insulin‐stimulated glucose uptake in 3T3‐L1 adipocytesFEBS Letters, 582
-
Systematic analysis of omentin 1 and omentin 2 on 1 q 23 as candidate genes for type 2 -
K. Müssig, H. Staiger, F. Machicao, C. Thamer, J. Machann, F. Schick, C. Claussen, N. Stefan, A. Fritsche, H. Häring (2009)
RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study.Metabolism: clinical and experimental, 58 4
-
E. Abraham, T. Huff, N. Cope, J. Wilson, E. Bransome, T. Huisman (1978)
Determination of the Glycosylated Hemoglobins (Hb AI) with a New Microcolumn Procedure: Suitability of the Technique for Assessing the Clinical Management of Diabetes MellitusDiabetes, 27
-
Celia Batista, Rongze Yang, Mi-Jeong Lee, Nicole Glynn, Daozhan Yu, Jessica Pray, Kelechi Ndubuizu, S. Patil, A. Schwartz, M. Kligman, S. Fried, D. Gong, A. Shuldiner, T. Pollin, J. Mclenithan (2007)
Omentin Plasma Levels and Gene Expression Are Decreased in ObesityDiabetes, 56
-
Mao Fu, C. Damcott, M. Sabra, T. Pollin, Sandra Ott, Jian Wang, M. Garant, J. O’Connell, B. Mitchell, A. Shuldiner (2004)
Polymorphism in the calsequestrin 1 (CASQ1) gene on chromosome 1q21 is associated with type 2 diabetes in the old order Amish.Diabetes, 53 12
-
S. Ritchie, J. Connell (2007)
The link between abdominal obesity, metabolic syndrome and cardiovascular disease.Nutrition, metabolism, and cardiovascular diseases : NMCD, 17 4
-
(1978)
mell - itus -
B. Tan, S. Pua, F. Syed, Krzysztof Lewandowski, Krzysztof Lewandowski, J. O'Hare, H. Randeva (2008)
Decreased plasma omentin‐1 levels in Type 1 diabetes mellitusDiabetic Medicine, 25
-
K. Bozaoglu, Kristy Bolton, J. McMillan, P. Zimmet, J. Jowett, G. Collier, K. Walder, D. Segal (2007)
Chemerin is a novel adipokine associated with obesity and metabolic syndrome.Endocrinology, 148 10
-
Y. Aso, S. Matsumoto, Y. Fujiwara, K. Tayama, T. Inukai, Y. Takemura (2002)
Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.Metabolism: clinical and experimental, 51 4
-
P. Trinder (1969)
Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen AcceptorAnnals of Clinical Biochemistry, 6
-
J. Siedel, E. Hägele, J. Ziegenhorn, A. Wahlefeld (1983)
Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency.Clinical chemistry, 29 6
-
(2003)
Cloning of omentin, a new adipocytokine from omental fat tissue in humans -
Xinyun Duan, Ping-Li Xie, Yu-lin Ma, S. Tang (2011)
Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathwayAmino Acids, 41
-
P. Zimmet, K. Alberti, J. Shaw (2001)
Global and societal implications of the diabetes epidemicNature, 414
-
Zhaoxia Wang, T. Nakayama (2010)
Inflammation, a Link between Obesity and Cardiovascular DiseaseMediators of Inflammation, 2010
-
B. Zabel, S. Allen, P. Kulig, J. Allen, J. Cichy, T. Handel, E. Butcher (2005)
Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades*Journal of Biological Chemistry, 280
-
W. Richmond (1973)
Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum.Clinical chemistry, 19 12
- Publisher
- Wiley
- Copyright
- © 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK
- ISSN
- 0742-3071
- eISSN
- 1464-5491
- DOI
- 10.1111/j.1464-5491.2011.03353.x
- pmid
- 21668495
- Publisher site
- See Article on Publisher Site
Abstract
Diabet. Med. 28, 1194–1200 (2011) Aims Omentin‐1 and chemerin have been identified as interesting novel adipokines that may modulate insulin action. Also, they have been suggested to be linked to obesity‐induced insulin resistance. The aim of this study was to analyse the relationship between these adipokines and interleukin‐6, insulin resistance and anthropometric and metabolic variables in patients with Type 2 diabetes mellitus and in patients with Type 2 diabetes who have ischaemic heart disease. Methods Seventy‐five individuals with Type 2 diabetes and 15 healthy control subjects were enrolled in this study. Insulin levels, interleukin‐6, omentin‐1 and chemerin were measured by ELISA. Results Serum omentin‐1 levels were found to be significantly decreased in patients with Type 2 diabetes (19.7 ± 1 ng/ml) and in patients with Type 2 diabetes with ischaemic heart disease (18.5 ± 1.6 ng/ml) compared with healthy control subjects (27.4 ± 2.6 ng/ml) at P < 0.01. Moreover, serum chemerin levels were found to be significantly increased in patients with Type 2 diabetes (347 ± 14 ng/ml) and in patients with Type 2 diabetes with ischaemic heart disease (341 ± 16.5 ng/ml) compared with healthy control subjects (281 ± 13 ng/ml) at P < 0.01. Interestingly, omentin‐1 and chemerin levels were found to be significantly correlated negatively with each other as well as being individually correlated with some selected anthropometric, biochemical and clinical variables. In conclusion, both omentin‐1 and chemerin might play as a pivotal role in obesity and its associated disorders as Type 2 diabetes; however, their role in cardiovascular diseases needs to be fully elucidated.
Journal
Diabetic Medicine – Wiley
Published: Oct 1, 2011